Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
NKTR
$60.55
+2.20%
NKTR
· Nektar Therapeutics
$60.55
+1.31 (+2.20%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$1.95B
Shares
34.14M
Volume · Sep 30
1.21M
Avg daily vol (3M)
928.13K
All earnings calls
Earnings call · FY2022 Q1
Nektar Therapeutics (NKTR) Q1 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$24.82M
+5% YoY
Diluted EPS
-$7.35
Net income
-$90.39M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed May 5, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed May 6, 2022 · complete as-filed document